An Observational Study in Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this trial is to investigate efficacy and
safety of NovoMix® 30 (biphasic insulin aspart 30) or Levemir® (insulin detemir) in subjects
with type 1 or 2 diabetes mellitus.